Ensuring the biologic safety of plasma-derived therapeutic proteins: detection, inactivation, and removal of pathogens (Q36088165)

12 August 2017

1 reference

title

Ensuring the biologic safety of plasma-derived therapeutic proteins: detection, inactivation, and removal of pathogens (English)

1 reference

12 August 2017

Kang Cai

1

1 reference

12 August 2017

Todd M Gierman

2

1 reference

12 August 2017

JoAnn Hotta

3

1 reference

12 August 2017

Christopher J Stenland

4

1 reference

12 August 2017

Douglas C Lee

5

1 reference

12 August 2017

Dominique Y Pifat

6

1 reference

12 August 2017

Steve R Petteway

7

1 reference

12 August 2017

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

19

1 reference

12 August 2017

79-96

1 reference

12 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.2165/00063030-200519020-00002

12 August 2017

0 references

cites work

Inactivation of lipid enveloped viruses by octanoic Acid treatment of immunoglobulin solution

1 reference

12 December 2020

Practical applications of the Australia antigen test

1 reference

12 December 2020

The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1.

1 reference

12 December 2020

Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis encephalitis viruses

1 reference

12 December 2020

The same prion strain causes vCJD and BSE

1 reference

12 December 2020

The transmissible spongiform encephalopathies

1 reference

12 December 2020

Inactivation of lipid-enveloped viruses in labile blood derivatives by unsaturated fatty acids

1 reference

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Assay of Australia antigen and antibody employing double-antibody and solid-phase radioimmunoassay techniques and comparison with the passive hemagglutination methods

1 reference

12 December 2020

Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.

1 reference

12 December 2020

Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques.

1 reference

12 December 2020

Transfusion-associated bacterial sepsis

1 reference

12 December 2020

Hepatitis C virus: quantitation and distribution in liver

1 reference

12 December 2020

Further studies on a "new" human isoprecipitin system (Australia antigen)

1 reference

12 December 2020

Creutzfeldt-Jakob disease and blood transfusion

1 reference

12 December 2020

HIV and the blood supply: an analysis of crisis decision making. Executive summary. The Institute of Medicine, National Academy of Sciences Committee to Study HIV Transmission Through Blood and Blood Products

1 reference

12 December 2020

1 reference

12 December 2020

An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques

1 reference

12 December 2020

Identification of scrapie infection from blood serum by Fourier transform infrared spectroscopy.

1 reference

12 December 2020

Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease.

1 reference

12 December 2020

Scrapie infectivity in hamster blood is not associated with platelets.

1 reference

12 December 2020

Retrospective neuropathological review of prion disease in UK haemophilic patients

1 reference

12 December 2020

Viral inactivation vs biological activity

1 reference

12 December 2020

Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors

1 reference

12 December 2020

Presence and persistence of Australian antigen in a Swedish hepatitis series

1 reference

12 December 2020

Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient

1 reference

12 December 2020

Parvovirus B19 transmission by heat-treated clotting factor concentrates

1 reference

12 December 2020

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

1 reference

12 December 2020

Inactivation of lipid-enveloped viruses in proteins by caprylate

1 reference

12 December 2020

Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group

1 reference

12 December 2020

Creutzfeldt-Jakob disease in the United States: 1979-1998

1 reference

12 December 2020

Epidemiology of Creutzfeldt-Jakob disease in the United States, 1979-1990: analysis of national mortality data

1 reference

12 December 2020

Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding

1 reference

12 December 2020

[Properties and efficacy of a human immunoglobulin M preparation for intravenous administration]

1 reference

12 December 2020

Organ distribution of prion proteins in variant Creutzfeldt-Jakob disease

1 reference

12 December 2020

Affinity chromatography in the industrial purification of plasma proteins for therapeutic use.

1 reference

12 December 2020

Detection of Australia Antigen and Antibody by Means of Radioimmunoassay Techniques

1 reference

12 December 2020

Prevalence of hepatitis C virus in plasma pools and the effectiveness of cold ethanol fractionation

1 reference

12 December 2020

A novel erythroid-specific marker of transmissible spongiform encephalopathies

1 reference

12 December 2020

Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids.

1 reference

12 December 2020

Reducing the risk of infection from plasma products: specific preventative strategies

1 reference

12 December 2020

Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein

1 reference

12 December 2020

1 reference

12 December 2020

Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients

1 reference

12 December 2020

Inactivation of parvovirus B19 during pasteurization of human serum albumin.

1 reference

12 December 2020

Current and emerging infectious risks of blood transfusions

1 reference

12 December 2020

Preparation of human immunoglobulin by caprylic acid precipitation

1 reference

12 December 2020

Antibody response to human immunodeficiency virus after primary infection

1 reference

12 December 2020

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

1 reference

12 December 2020

A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins

1 reference

12 December 2020

Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group

1 reference

12 December 2020

Inactivation of transmissible degenerative encephalopathy agents: A review

1 reference

12 December 2020

A World Health Organization International Standard for hepatitis A virus RNA nucleic acid amplification technology assays

1 reference

12 December 2020

Eight prion strains have PrP(Sc) molecules with different conformations

1 reference

12 December 2020

Prion protein and the transmissible spongiform encephalopathy diseases

1 reference

12 December 2020

Variation in the sensitivity of HBsAg screening kits

1 reference

12 December 2020

Efficacy of viral clearance methods used in the manufacture of activated prothrombin complex concentrates: focus on AUTOPLEX T.

1 reference

12 December 2020

Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma.

1 reference

12 December 2020

Transmission of prion diseases by blood transfusion

1 reference

12 December 2020

Solvent-dependent precipitation of prion protein

1 reference

12 December 2020

Determination of adequate moisture content for efficient dry-heat viral inactivation in lyophilized factor VIII by loss on drying and by near infrared spectroscopy.

1 reference

12 December 2020

Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent

1 reference

12 December 2020

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

1 reference

12 December 2020

Surveillance for Creutzfeldt-Jakob disease among persons with hemophilia

1 reference

12 December 2020

1 reference

12 December 2020

Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans

1 reference

12 December 2020

Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets

1 reference

12 December 2020

Good manufacturing practice (GMP) compliance in the biologics sector: plasma fractionation

1 reference

12 December 2020

Transmission of BSE by blood transfusion in sheep

1 reference

12 December 2020

Diagnostic value of the strand displacement amplification method compared to those of Roche Amplicor PCR and culture for detecting mycobacteria in sputum samples.

1 reference

12 December 2020

Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.

1 reference

12 December 2020

Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. WHO Collaborative Study Group

1 reference

12 December 2020

Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein

1 reference

12 December 2020

International standardization of gene amplification technology.

1 reference

12 December 2020

Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity

1 reference

12 December 2020

Evaluation of virus and prion reduction in a new intravenous immunoglobulin manufacturing process

1 reference

12 December 2020

Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates

1 reference

12 December 2020

The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy.

1 reference

12 December 2020

An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques

1 reference

12 December 2020

Australia antigen in volunteer and paid blood donors

1 reference

12 December 2020

Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator Group

1 reference

12 December 2020

Purity of spiking agent affects partitioning of prions in plasma protein purification

1 reference

12 December 2020

Detection of HCV RNA by the asymmetric gap ligase chain reaction

1 reference

12 December 2020

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

12 December 2020

Scrapie removal using Planova virus removal filters

1 reference

12 December 2020

Inactivation of hepatitis A virus in plasma products by vapor heating

1 reference

12 December 2020

Properties of a new intravenous immunoglobulin (IGIV-C, 10%) produced by virus inactivation with caprylate and column chromatography

1 reference

12 December 2020

Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

1 reference

12 December 2020

NASBATM isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection

1 reference

12 December 2020

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

1 reference

12 December 2020

Virus-like particles in serum of patients with Australia-antigen-associated hepatitis

1 reference

12 December 2020

Calibration of HCV working reagents for NAT assays against the HCV international standard. The Collaborative Study Group

1 reference

12 December 2020

Virus-like particles in serum of patients with Australia-antigen-associated hepatitis

1 reference

12 December 2020

Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease

1 reference

12 December 2020

Nanofiltration of plasma-derived biopharmaceutical products

1 reference

12 December 2020

Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin.

1 reference

12 December 2020

Direct Detection of HIV-1 RNA from AIDS and ARC Patient Samples

1 reference

12 December 2020

Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues

1 reference

12 December 2020

Peripheral pathogenesis of prion diseases

1 reference

12 December 2020

Calibration of HIV-1 working reagents for nucleic acid amplification techniques against the 1st international standard for HIV-1 RNA.

1 reference

12 December 2020

Stabilization of Serum Albumin to Heat, and Inactivation of the Hepatitis Virus

1 reference

12 December 2020

Immunopathogenesis of HIV infection

1 reference

12 December 2020

Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection

1 reference

12 December 2020

Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products

1 reference

12 December 2020

Creutzfeldt-Jakob disease in mice: persistent viremia and preferential replication of virus in low-density lymphocytes.

1 reference

12 December 2020

Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2.

1 reference

12 December 2020

[Isolation of IgG immunoglobulin from human plasma using caprylic acid]

1 reference

12 December 2020

Clinical spectrum of human retroviral-induced diseases

1 reference

12 December 2020

Australia Antigen: Distribution during Cohn Ethanol Fractionation of Human Plasma

1 reference

12 December 2020

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

12 December 2020

Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products

1 reference

12 December 2020

A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan

1 reference

12 December 2020

Australia antigen in various plasma fractions

1 reference

12 December 2020

10.2165/00063030-200519020-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference